Question 1

What is Guardant Health?

Accepted Answer

Guardant Health is a Company.

Question 2

How often does Guardant Health appear in global news?

Accepted Answer

Tracked across 4 news events drawn from 29 articles.

Question 3

When was Guardant Health first tracked by Ergen?

Accepted Answer

First tracked on Jun 04, 2026.

Question 4

When was Guardant Health last mentioned in news?

Accepted Answer

Last active on Jul 27, 2026.

Question 5

What is Guardant Health's current news sentiment?

Accepted Answer

Aggregate sentiment score: 31 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Guardant Health in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 4 events.

Question 7

What is the most recent event involving Guardant Health?

Accepted Answer

FDA approves Guardant360 CDx for HERNEXEOS (Jun 11, 2026, 7 articles).

Question 8

How did the "FDA approves Guardant360 CDx for HERNEXEOS" event impact Guardant Health?

Accepted Answer

Guardant Health received FDA approval for its Guardant360 CDx liquid biopsy test, expanding its utility as a companion diagnostic for HERNEXEOS. This approval enhances the company's market position and potential revenue streams.

Question 9

How did the "Zydus, Apollo, Guardant Partner for Cancer Test in India" event impact Guardant Health?

Accepted Answer

Guardant Health has an exclusive agreement with Astec LifeSciences to make its Shield Multi-Cancer Detection test available in India, expanding its global market presence for innovative cancer screening technology.

Question 10

How did the "FDA approves Freenome's SimpleScreen CRC test" event impact Guardant Health?

Accepted Answer

Guardant Health faces increased competition from SimpleScreen CRC, which offers similar blood-based screening.

Question 11

How did the "Blood Test Predicts Lung Cancer" event impact Guardant Health?

Accepted Answer

'Guardant Health' is developing a multi-cancer screening tool, Shield, which shows promise for lung cancer applications, contributing to advancements in early detection.

Question 12

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.